These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 14593960

  • 1. [The results of conservative treatment of oxalate urolithiasis in children].
    Rogowska-Kalisz A, Tkaczyk M, Bilińska W, Nowicki M.
    Pol Merkur Lekarski; 2003 Jul; 15(85):51-4. PubMed ID: 14593960
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B, von Unruh GE, Blank G, Rietschel E, Sidhu H, Laube N, Hesse A.
    Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Population based data on urinary excretion of calcium, magnesium, oxalate, phosphate and uric acid in children from Cimitile (southern Italy).
    De Santo NG, Di Iorio B, Capasso G, Paduano C, Stamler R, Langman CB, Stamler J.
    Pediatr Nephrol; 1992 Mar; 6(2):149-57. PubMed ID: 1571211
    [Abstract] [Full Text] [Related]

  • 11. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P, Portmann L, Jacquet AF, Burckhardt P.
    Schweiz Med Wochenschr; 1986 Dec 13; 116(50):1783-6. PubMed ID: 3798070
    [Abstract] [Full Text] [Related]

  • 12. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.
    Milliner DS, Wilson DM, Smith LH.
    Kidney Int; 2001 Jan 13; 59(1):31-6. PubMed ID: 11135054
    [Abstract] [Full Text] [Related]

  • 13. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
    Milosević D, Batinić D, Konjevoda P, Blau N, Stambuk N, Nizić L, Vrljicak K, Batinić D.
    J Chem Inf Comput Sci; 2003 Jan 13; 43(6):1844-7. PubMed ID: 14632431
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
    Penniston KL, Nakada SY.
    Urology; 2009 Mar 13; 73(3):484-9. PubMed ID: 19118878
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers.
    Siener R, Ebert D, Nicolay C, Hesse A.
    Kidney Int; 2003 Mar 13; 63(3):1037-43. PubMed ID: 12631085
    [Abstract] [Full Text] [Related]

  • 19. Prophylaxis of oxalate urolithiasis with alkaline citrates.
    Frang D, Berényi M, Szebeni R.
    Ther Hung; 1990 Mar 13; 38(2):64-70. PubMed ID: 2377983
    [Abstract] [Full Text] [Related]

  • 20. Promoters and inhibitors of calcium urolithiasis in children.
    Lama G, Carbone MG, Marrone N, Russo P, Spagnuolo G.
    Child Nephrol Urol; 1990 Mar 13; 10(2):81-4. PubMed ID: 2253256
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.